Events - Future Events View
The event calendar shows upcoming club events. Select a view then use the navigation buttons to move
between dates. Click on the event to view more information, including the event description, times,
location, fees and any rules regarding attendance; you can also register for events from this screen.
Click on the magnifying glass on the toolbar to see search and filter options.
Tue, Oct 27, 2026 at 7:00 PM
Presented by: Daniel R. Seichepine, Ph.D.
About the Webinar: Recent advances in blood-based biomarkers, genetic testing, and disease-modifying therapies are transforming how Alzheimer‘s disease is diagnosed and treated. These developments also raise important questions about the evolving role of clinical neuropsychologists.
This presentation will review emerging Alzheimer‘s disease biomarkers, the clinical significance of APOE genotype, and the benefits and limitations of anti-amyloid monoclonal antibody therapies. Particular emphasis will be placed on how neuropsychologists can contribute to early identification, differential diagnosis, and treatment eligibility decisions. Practical examples from clinical evaluations will illustrate how these advances can be integrated into neuropsychological practice.